GLP-1的市场扩张,直接推动多肽CDMO行业进入热潮期。2025年上半年,司美格鲁肽与替尔泊肽合计销售额超300亿美元,市场前景一片繁荣。据弗若斯特沙利文预测,全球多肽药物市场至2032年将达2612亿美元,年复合增长率约12.6%;其中GLP-1赛道增速更高。目前全球约65%的多肽原料药生产采用外包模式,而中国市场的发展速度快于全球,预计2030年国内多肽CDMO规模将达185亿元。在此背景下...
Source LinkGLP-1的市场扩张,直接推动多肽CDMO行业进入热潮期。2025年上半年,司美格鲁肽与替尔泊肽合计销售额超300亿美元,市场前景一片繁荣。据弗若斯特沙利文预测,全球多肽药物市场至2032年将达2612亿美元,年复合增长率约12.6%;其中GLP-1赛道增速更高。目前全球约65%的多肽原料药生产采用外包模式,而中国市场的发展速度快于全球,预计2030年国内多肽CDMO规模将达185亿元。在此背景下...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.